Seek Expert Guidance for Benign Prostatic Hyperplasia Management
Benign Prostatic Hyperplasia (BPH), commonly referred to as prostate enlargement, is a prevalent concern predominantly affecting aging males. While not life-threatening, it significantly impacts the quality of life due to various urinary symptoms. Fortunately, modern treatment options offer effective relief. However, navigating these options requires the expertise of a seasoned medical professional. A/Prof Homi Zargar provides personalized care and comprehensive treatment for BPH in Melbourne, Australia.
Identifying Common Symptoms of Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia manifests through several common symptoms, including:
Constriction of the urethra due to prostate enlargement, leading to urinary difficulties.
Increased frequency of urination due to increased workload of the bladder.
Incomplete bladder emptying, causing frequency and sleep disturbances.
Urgent need to urinate, potentially causing inconvenience in reaching the restroom promptly.
Exploring Treatment Options for Benign Prostatic Hyperplasia
A/Prof Homi Zargar offers state-of-the-art urological care, focusing on patient-centered solutions. Treatment avenues for BPH encompass:
Lifestyle adjustments: Incorporating bladder training exercises, limiting caffeine and alcohol intake, and managing fluid consumption before bedtime to mitigate night-time urination and improve sleep quality.
Pharmacotherapy: Prescribing medications such as alpha-blockers and 5-alpha reductase inhibitors to alleviate urinary symptoms and reduce prostate gland size.
Minimally invasive procedures: Employing techniques like Urolift and Rezum as well as the latest upcoming techniques in clinical trial setting.
Surgical interventions: Performing procedures like Transurethral Resection of the Prostate (TURP) , Holmium Laser Enucleation of the Prostate (HoLEP), and robotic simple prostatectomy to alleviate urinary obstruction and manage symptoms effectively.
A/Prof Homi Zargar's expertise extends beyond benign prostatic hyperplasia, encompassing urological oncology and addressing common comorbidities associated with aging men and women.